mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0009 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.004 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.005 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.005 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
0.007 |